Literature DB >> 24811557

Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

Chang-Ho Ryan Choi1, Sang Oh Lee, Geoff Smith.   

Abstract

The authors present an unusual case of a 51-year-old man who developed relatively mild non-specific symptoms following intravesical BCG instillation for superficial transitional cell carcinoma of the bladder, with radiological investigations demonstrating typical features of miliary tuberculosis (TB). Transbronchial biopsy showed small foci of poorly formed granuloma suggestive of Mycobacterium infection. The patient's respiratory symptoms only became apparent 7 days after discharge having had 4 weeks of unremarkable inpatient stay where he remained clinically well. Prompt anti-TB treatment resulted in a remarkable improvement in his symptoms and radiological appearance, supporting the diagnosis of disseminated Mycobacterium bovis infection. This case highlights the importance of recognising miliary M bovis as a potential complication in patients receiving BCG immunotherapy, and that the disease course can be subclinical with delayed onset of symptoms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24811557      PMCID: PMC4024537          DOI: 10.1136/bcr-2013-201202

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  36 in total

Review 1.  Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer.

Authors:  M Elkabani; J N Greene; A L Vincent; S VanHook; R L Sandin
Journal:  Cancer Control       Date:  2000 Sep-Oct       Impact factor: 3.302

Review 2.  Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.

Authors:  Daher C Chade; Shahrokh F Shariat; Guido Dalbagni
Journal:  Int Braz J Urol       Date:  2009 Nov-Dec       Impact factor: 1.541

3.  Miliary tuberculosis secondary to transurethral bacillus Calmette-Guérin administration for superficial transitional cell carcinoma of the bladder.

Authors:  A Skoutelis; M D Melekos; H J Bassaris
Journal:  J Natl Cancer Inst       Date:  1990-07-18       Impact factor: 13.506

4.  Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.

Authors:  L R Kavoussi; E J Brown; J K Ritchey; T L Ratliff
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Miliary tuberculosis due to intravesical bacillus Calmette-Guerin therapy.

Authors:  R C Gupta; R Lavengood; J P Smith
Journal:  Chest       Date:  1988-12       Impact factor: 9.410

6.  Sensitivity of BCG to modern antibiotics.

Authors:  C Durek; S Rüsch-Gerdes; D Jocham; A Böhle
Journal:  Eur Urol       Date:  2000       Impact factor: 20.096

7.  Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.

Authors:  Hirofumi Koga; Masao Kuroda; Seiji Kudo; Akito Yamaguchi; Michiyuki Usami; Tadashi Suzuki; Seiji Naito
Journal:  Int J Urol       Date:  2005-02       Impact factor: 3.369

8.  A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics.

Authors:  S Krege; G Giani; R Meyer; T Otto; H Rübben
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

Review 9.  Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.

Authors:  D L Lamm
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

10.  Disseminated infection after intravesical BCG immunotherapy. Detection of organisms in pulmonary tissue.

Authors:  M Palayew; D Briedis; M Libman; R P Michel; R D Levy
Journal:  Chest       Date:  1993-07       Impact factor: 9.410

View more
  2 in total

1.  BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas and a mycotic aortic aneurysm.

Authors:  David Mark Smith
Journal:  BMJ Case Rep       Date:  2016-07-14

2.  Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.

Authors:  Kyohei Kaburaki; Keishi Sugino; Muneyuki Sekiya; Yujiro Takai; Kazutoshi Shibuya; Sakae Homma
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.